Does Tarsus Pharmaceuticals Inc. (NASDAQ:TARS) have deteriorating prospects?
Tarsus Pharmaceuticals Inc. (NASDAQ:TARS) shares traded -5.53% lower at $17.26 on Wall Street last session. In accordance with the data, 9 analysts cover Tarsus Pharmaceuticals Inc. (NASDAQ:TARS). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $70.00 and a low of $40.00, […]
